The drugs in our pipeline offer a new mechanism focused on PDE4B and PDE4D.
Treat cognitive impairment and memory loss by improving how the brain processes and stores information. Working with potentially breakthrough technology, our goal is to improve the quality of life in patients suffering from:
Fragile X Syndrome | Alzheimer’s Disease | Dementias
Traumatic Brain Injury | Major Psychiatric Diseases